RSNA 2009 

Abstract Archives of the RSNA, 2009


SSJ20-04

In Vivo Measurements of Human Blood T1 Trend after the Administration of Gadobenate Dimeglumine

Scientific Papers

Presented on December 1, 2009
Presented as part of SSJ20: Physics (MR Imaging: Diffusion and Perfusion)

Participants

Michele Anzidei MD, Presenter: Nothing to Disclose
Alessandro Napoli MD, Abstract Co-Author: Nothing to Disclose
Carlo Catalano MD, Abstract Co-Author: Nothing to Disclose
Roberto Passariello MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To measure the T1 trend in blood after the administration of Gadobenate Dimeglumine (Gd-BOPTA, MultiHance®, Bracco Spa, Milan - Italy) in humans.

METHOD AND MATERIALS

In a pilot study for parameters optimization, the T1-shortening induced by the injection of a single dose (0.1 mmol/kg body weight) of the MR contrast agent MultiHance® was measured at B0=1.5 T as a function of time. In four sessions, T1 measurements were performed in the carotid artery of 10 volunteers up to 30 min after injection. T1 times were measured using 2D IR-FLASH sequences: 10 images acquired with different TI were used to evaluate the T1 before contrast administration, while three 2D IR-FLASH with different TI (130, 800 and 3000 ms) were performed for each time point after contrast agent injection.

RESULTS

The 2D IR-FLASH measurements showed T1 times of about 130 ms immediately after injection, which gradually increased to 400 ms at 30 min. The time curve of the R1=1/T1 averaged over all volunteers could be described with a bi-exponential decay with time constants C1 = 380+/-70 s and C2 = 5600+/-126 s, amplitude A1= 4.3+/-0.3 s-1 and A2=2.7+/-0.3 s-1 respectively, and a constant offset of R1(0)=0.5+/-0.2 s-1. Mean relaxation values are in excellent agreement with theoretical predictions.

CONCLUSION

An analytical expression for the initial T1-shortening of MultiHance® was derived which can now be used for optimization of the pulse sequence parameters in clinical studies.

CLINICAL RELEVANCE/APPLICATION

The trend of T1 values of blood during the administration of Multihance® can be used to optimize sequence protocols for MR-angiography.

Cite This Abstract

Anzidei, M, Napoli, A, Catalano, C, Passariello, R, In Vivo Measurements of Human Blood T1 Trend after the Administration of Gadobenate Dimeglumine.  Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8006775.html